ZA968783B - Flupirtine usage - Google Patents

Flupirtine usage

Info

Publication number: ZA968783B
Authority: ZA; South Africa
Prior art keywords: flupirtine; usage; patients; prophylaxis; impairment
Prior art date: 1995-11-07

Application number

ZA968783A

Other languages

English (en)

Inventor

Gabriela Dr Pergande

Werner E G Prof Mueller

Original Assignee

Asta Medica Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-11-07

Filing date

1996-10-18

Publication date

1997-05-27

1996-10-18 Application filed by Asta Medica Ag filed Critical Asta Medica Ag

1997-05-27 Publication of ZA968783B publication Critical patent/ZA968783B/xx

Links

JUUFBMODXQKSTD-UHFFFAOYSA-N N-[2-amino-6-[(4-fluorophenyl)methylamino]-3-pyridinyl]carbamic acid ethyl ester Chemical compound N1=C(N)C(NC(=O)OCC)=CC=C1NCC1=CC=C(F)C=C1 JUUFBMODXQKSTD-UHFFFAOYSA-N 0.000 title abstract 2
229960003667 flupirtine Drugs 0.000 title abstract 2
208000030507 AIDS Diseases 0.000 abstract 1
210000004027 cell Anatomy 0.000 abstract 1
230000006735 deficit Effects 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
210000004698 lymphocyte Anatomy 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Diabetes (AREA)
Hematology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Polyurethanes Or Polyureas (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pyridine Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

ZA968783A 1995-11-07 1996-10-18 Flupirtine usage ZA968783B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19541405A DE19541405A1 (de)	1995-11-07	1995-11-07	Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen

Publications (1)

Publication Number	Publication Date
ZA968783B true ZA968783B (en)	1997-05-27

Family

ID=7776799

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA968783A ZA968783B (en)	1995-11-07	1996-10-18	Flupirtine usage

Country Status (26)

Country	Link
US (2)	US6034111A (da)
EP (1)	EP0859613B1 (da)
JP (1)	JPH11514652A (da)
KR (1)	KR100512673B1 (da)
CN (1)	CN1116037C (da)
AT (1)	ATE316789T1 (da)
AU (1)	AU711207B2 (da)
BG (1)	BG63149B1 (da)
BR (1)	BR9611588A (da)
CA (1)	CA2189705C (da)
CZ (1)	CZ298115B6 (da)
DE (2)	DE19541405A1 (da)
DK (1)	DK0859613T3 (da)
ES (1)	ES2257755T3 (da)
HU (1)	HU225742B1 (da)
MX (1)	MX9803610A (da)
NO (1)	NO315074B1 (da)
NZ (1)	NZ330414A (da)
PL (1)	PL186537B1 (da)
PT (1)	PT859613E (da)
RU (1)	RU2200555C2 (da)
SK (1)	SK284601B6 (da)
TW (1)	TW393317B (da)
UA (1)	UA51682C2 (da)
WO (1)	WO1997017072A2 (da)
ZA (1)	ZA968783B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19625582A1 (de) *	1996-06-27	1998-01-02	Asta Medica Ag	Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen die mit einer unphysiologisch hohen Zellsterberate einhergehen
US6821995B1 (en)	1999-12-01	2004-11-23	Duke University	Method of treating batten disease
DE10327674A1 (de)	2003-06-20	2005-01-05	Awd.Pharma Gmbh & Co. Kg	Injizierbare Darreichungsform von Flupirtin
EP1688141A1 (en) *	2005-01-31	2006-08-09	elbion AG	The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
US20080279930A1 (en) *	2007-05-07	2008-11-13	Bernd Terhaag	Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
DE102009023162B4 (de) *	2009-05-29	2011-07-07	Corden PharmaChem GmbH, 68305	Verfahren zur Herstellung von Flupirtin
US9212416B2 (en) *	2009-08-07	2015-12-15	Swagelok Company	Low temperature carburization under soft vacuum
DE102010030053A1 (de)	2010-06-14	2011-12-15	Awd.Pharma Gmbh & Co.Kg	Injizierbare Darreichungsform von Flupirtin
JP2015508789A (ja) *	2012-03-02	2015-03-23	メダファーマゲゼルシャフトミットベシュレンクテルハフツングウントコンパニーコマンディトゲゼルシャフト	医薬製剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IN172468B (da) *	1990-07-14	1993-08-14	Asta Medica Ag
DE4327516A1 (de) *	1993-08-17	1995-02-23	Asta Medica Ag	Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin

1995
- 1995-11-07 DE DE19541405A patent/DE19541405A1/de not_active Ceased
1996
- 1996-10-18 ZA ZA968783A patent/ZA968783B/xx unknown
- 1996-10-23 JP JP9517734A patent/JPH11514652A/ja active Pending
- 1996-10-23 HU HU9901659A patent/HU225742B1/hu not_active IP Right Cessation
- 1996-10-23 RU RU98111152/14A patent/RU2200555C2/ru not_active IP Right Cessation
- 1996-10-23 WO PCT/DE1996/002009 patent/WO1997017072A2/de not_active Ceased
- 1996-10-23 CN CN96198131A patent/CN1116037C/zh not_active Expired - Fee Related
- 1996-10-23 KR KR10-1998-0703376A patent/KR100512673B1/ko not_active Expired - Fee Related
- 1996-10-23 PT PT96945822T patent/PT859613E/pt unknown
- 1996-10-23 PL PL96326629A patent/PL186537B1/pl not_active IP Right Cessation
- 1996-10-23 CZ CZ0128398A patent/CZ298115B6/cs not_active IP Right Cessation
- 1996-10-23 BR BR9611588A patent/BR9611588A/pt not_active Application Discontinuation
- 1996-10-23 ES ES96945822T patent/ES2257755T3/es not_active Expired - Lifetime
- 1996-10-23 SK SK586-98A patent/SK284601B6/sk not_active IP Right Cessation
- 1996-10-23 DK DK96945822T patent/DK0859613T3/da active
- 1996-10-23 UA UA98062946A patent/UA51682C2/uk unknown
- 1996-10-23 EP EP96945822A patent/EP0859613B1/de not_active Expired - Lifetime
- 1996-10-23 AU AU17165/97A patent/AU711207B2/en not_active Ceased
- 1996-10-23 NZ NZ330414A patent/NZ330414A/en unknown
- 1996-10-23 AT AT96945822T patent/ATE316789T1/de active
- 1996-10-23 DE DE59611327T patent/DE59611327D1/de not_active Expired - Lifetime
- 1996-11-04 TW TW085113437A patent/TW393317B/zh not_active IP Right Cessation
- 1996-11-06 CA CA002189705A patent/CA2189705C/en not_active Expired - Fee Related
- 1996-11-07 US US08/744,953 patent/US6034111A/en not_active Expired - Lifetime
1998
- 1998-04-16 US US09/061,099 patent/US6034112A/en not_active Expired - Lifetime
- 1998-04-24 BG BG102404A patent/BG63149B1/bg unknown
- 1998-04-27 NO NO19981898A patent/NO315074B1/no not_active IP Right Cessation
- 1998-05-07 MX MX9803610A patent/MX9803610A/es not_active IP Right Cessation

Also Published As

Publication number	Publication date
TW393317B (en)	2000-06-11
HU225742B1 (en)	2007-07-30
BR9611588A (pt)	1999-04-06
KR100512673B1 (ko)	2005-12-09
NO981898L (no)	1998-04-27
DE19541405A1 (de)	1997-05-15
SK284601B6 (sk)	2005-07-01
KR19990067366A (ko)	1999-08-16
NZ330414A (en)	1999-10-28
CZ298115B6 (cs)	2007-06-27
BG102404A (en)	1998-12-30
DE59611327D1 (de)	2006-04-13
HK1016508A1 (en)	1999-11-05
UA51682C2 (uk)	2002-12-16
JPH11514652A (ja)	1999-12-14
MX9803610A (es)	1998-09-30
CN1116037C (zh)	2003-07-30
WO1997017072A3 (de)	1997-07-24
NO981898D0 (no)	1998-04-27
CA2189705A1 (en)	1997-05-08
US6034111A (en)	2000-03-07
CN1201391A (zh)	1998-12-09
CZ128398A3 (cs)	1998-09-16
ATE316789T1 (de)	2006-02-15
RU2200555C2 (ru)	2003-03-20
AU711207B2 (en)	1999-10-07
WO1997017072A2 (de)	1997-05-15
NO315074B1 (no)	2003-07-07
EP0859613A2 (de)	1998-08-26
HUP9901659A3 (en)	2001-04-28
DK0859613T3 (da)	2006-06-06
HUP9901659A2 (hu)	1999-09-28
PT859613E (pt)	2006-06-30
BG63149B1 (bg)	2001-05-31
SK58698A3 (en)	1998-09-09
ES2257755T3 (es)	2006-08-01
US6034112A (en)	2000-03-07
PL326629A1 (en)	1998-10-12
PL186537B1 (pl)	2004-01-30
AU1716597A (en)	1997-05-29
EP0859613B1 (de)	2006-02-01
CA2189705C (en)	2005-08-09

Similar Documents

Publication	Publication Date	Title
AU586860B2 (en)	1989-07-27	Therapeutical application of phosphonylmethoxyalkyl adenines
TW376320B (en)	1999-12-11	Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
TW371660B (en)	1999-10-11	Therapeutic nucleosides a purine carbocyclic nucleosides for treatment of HIV and HBV infections
YU18899A (sh)	2002-09-19	L-nukleozidi purina, njihovi analogoni i primena
MY117892A (en)	2004-08-30	Therapeutic compounds
FI956014A0 (fi)	1995-12-14	Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
IE900073L (en)	1990-07-26	Treatment of diseases associated with hiv infections
DK0855916T3 (da)	2004-10-18	Farmaceutisk præparat indeholdende en Activin-stimulator
AU1716597A (en)	1997-05-29	Use of flupirtine for the prophylaxis and therapy of diseases associated with an impairment of the haemopoietic cell system
AP9801286A0 (en)	1998-09-30	Therapeutic compounds.
MY105855A (en)	1995-02-28	Therapeutic nucleotides.
NZ512850A (en)	2004-01-30	Treatment of papillomavirus infections
MD970254A (en)	1999-05-31	Use of melatonine for treatment of patients having a medicamental dependence
AU2880595A (en)	1996-01-25	Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
AU4111600A (en)	2000-12-12	The use of gssg reductase for the therapy and prophylaxis of hiv infected patients
MX9700560A (es)	1997-05-31	Metodo de uso de integrasa retroviral negativa transdominante en el tratamiento de infecciones retrovirales.
AU5535498A (en)	1998-08-20	Treatment of HIV positive patients
AU2211592A (en)	1993-04-29	Method of treatment for latent virus infection
AU2396900A (en)	2000-07-31	Treatment and prevention of hiv and other viral infections
MD1051C2 (ro)	1999-05-31	Remediu antiherpetic
AU2450900A (en)	2000-08-29	Therapeutic nucleoside compound
ES8700940A1 (es)	1986-11-16	Procedimiento de obtencion de composiciones para el trata- miento de infecciones por rinovirus
WO1988008707A3 (en)	1988-12-29	Rubradirin derivatives for treatment of hiv infection
GR1002968B (el)	1998-09-09	Φαρμακευτικο παρασκευασμα βασιζομενο σε εναιωρημα εμβρυικων κυτταρων με ανοσοδιορθωτικη δραση και μεθοδος θεραπειας ζαχαρωδους διαβητη με τη χρηση αυτου του παρασκευασματος.
AU2880495A (en)	1996-01-25	Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses